CagriSema is highly effective, but tirzepatide (Zepbound) edges it out in a direct comparison
In clinical trials, patients achieved weight loss of approximately 15-20% from baseline after 72 weeks, with results varying by dose and whether patients had diabetes
:
The hijacking of the cellular machinery by viruses was proposed to explain the mechanism [6]
Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps
If affordability is your number one concern, Hers is one of the lowest-cost entry points to GLP-1 care